These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia. Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593 [No Abstract] [Full Text] [Related]
3. [Treatment of hyperuricemia and gout]. Gröbner W; Walter-Sack I Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988 [No Abstract] [Full Text] [Related]
4. [Hyperuricemia. When and how to treat?]. Reuss-Borst MA Internist (Berl); 2016 Feb; 57(2):194-201. PubMed ID: 26791735 [TBL] [Abstract][Full Text] [Related]
5. [Hyperuricemia, gout, pseudogout and concomitant diseases]. Schmidt BM; Wagner AD Dtsch Med Wochenschr; 2011 Dec; 136(48):2489-91. PubMed ID: 22109583 [No Abstract] [Full Text] [Related]
6. Dermal tophus: a complication of gout in a kidney transplant recipient. Ayvazoglu Soy EH; Karakaya E; Karatas Togral A; Akdur A; Moray G; Haberal M Exp Clin Transplant; 2015 Apr; 13 Suppl 1():276-9. PubMed ID: 25894172 [TBL] [Abstract][Full Text] [Related]
7. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients. Osadchuk L; Bashir MH; Tangirala B; Marcus RJ; Nashar K; Hussain SM; Sureshkumar KK Exp Clin Transplant; 2014 Jun; 12(3):190-4. PubMed ID: 24907717 [TBL] [Abstract][Full Text] [Related]
8. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. Dalbeth N; Kumar S; Stamp L; Gow P J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857 [TBL] [Abstract][Full Text] [Related]
11. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia. Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549 [TBL] [Abstract][Full Text] [Related]
12. Update on gout and hyperuricemia. Baker JF; Schumacher HR Int J Clin Pract; 2010 Feb; 64(3):371-7. PubMed ID: 19909378 [TBL] [Abstract][Full Text] [Related]
13. [Febuxostat versus allopurinol for hyperuricemia]. Ziegler R Med Monatsschr Pharm; 2006 Oct; 29(10):384. PubMed ID: 17058902 [No Abstract] [Full Text] [Related]
14. New therapeutic approach to hyperuricemia and gout in the light of recommendations. Lioté F Joint Bone Spine; 2016 Jul; 83(4):376-80. PubMed ID: 27085801 [No Abstract] [Full Text] [Related]
15. [Hyperuricemia/gout. Main symptoms of arthropathy. Severe acute joint pain, redness, inflammation]. Kolyvanos Naumann U; Suter PM; Käser L; Vetter W Praxis (Bern 1994); 2005 Apr; 94(14):543-8; quiz 549. PubMed ID: 15849976 [No Abstract] [Full Text] [Related]
17. Febuxostat--treatment for hyperuricemia and gout? Moreland LW N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099 [No Abstract] [Full Text] [Related]
18. [Gout]. Gröbner W; Zöllner N Z Rheumatol; 2004 Feb; 63(1):2-9. PubMed ID: 14991273 [TBL] [Abstract][Full Text] [Related]
19. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease. Torres RJ; Puig JG Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316 [TBL] [Abstract][Full Text] [Related]
20. Are hyperuricemia and gout different diseases? Comment on the guidelines for the diagnosis and management of hyperuricemia and gout with the healthcare professional perspectives in China. Li Y; Lin Z; Wang Y; Wu H; Zhang B Int J Rheum Dis; 2023 Sep; 26(9):1866-1868. PubMed ID: 36719050 [No Abstract] [Full Text] [Related] [Next] [New Search]